Trxade Team

The agency continues to work to ensure a supply of safe, effective, and cost-saving generic drugs, each manufactured under our rigorous quality standards. Generic drugs account for 90 percent of the prescriptions dispensed in the U.S., saving the health care system about $1.67 trillion.

Late-stage ovarian cancer patients have few options, but now the FDA is reviewing GSK's Zejula for the patient group. GSK picked up the med in last year's Tesaro buyout.